Clinical trials
Ventricular Tachycardia, Monomorphic clinical trials
Below are recruiting ventricular tachycardia, monomorphic clinical trials, each written for real people, not researchers. We’re tracking 17 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07650032Recruiting
Freezing Treatment for Abnormal Heart Rhythms
This trial tests a freezing catheter procedure to treat dangerous, recurring abnormal heart rhythms (ventricular tachycardia) in patients whose hearts are weakened and whose current medications haven't worked. The procedure aims to scar the tissue causing the arrhythmia so your heart beats normally again.
Phoenix, ArizonaAges 18 years+ - NCT03713866Recruiting
Imaging heart scar during ablation for certain fast heart rhythms
This trial uses special heart imaging during a catheter ablation to better map scar tissue that may be causing a dangerous fast heart rhythm (monomorphic ventricular tachycardia). It may help doctors target the problem more accurately during the procedure.
Halifax, Nova ScotiaAges 18–85 - NCT06138873Recruiting
Study of scar-guided ablation for ventricular tachycardia
This trial is testing a new approach to treating a fast, dangerous heart rhythm (ventricular tachycardia) that comes from scar tissue in people with ischemic cardiomyopathy. The goal is to use a special mapping technique to guide the ablation (a procedure that destroys the tiny area causing the problem) to stop the arrhythmia.
Chicago, IllinoisAges 18 years+ - NCT06891456Recruiting
Pulsed field ablation for ventricular tachycardia after heart attack
This trial tests a new type of energy (pulsed field ablation) to treat a fast heart rhythm called ventricular tachycardia that happens after a heart attack. The goal is to stop the dangerous rhythm without damaging nearby healthy tissue.
Cleveland, OhioAges 18 years+ - NCT06360939Recruiting
Radiation or ablation for ventricular tachycardia in heart disease
This trial compares two treatments—radiation therapy or catheter ablation—for people with structural heart disease who have a type of fast heart rhythm called ventricular tachycardia. It aims to see which approach works better to prevent repeat episodes.
WestmeadAges 18 years+ - NCT06747013Enrolling by invitation
Focused pulse field ablation for ventricular tachycardia
This trial tests a new way to treat rapid heartbeats from the lower chambers (ventricles) using a special catheter that delivers short electrical pulses to stop the abnormal signals. It may help people with extra beats (PVCs) or a fast heart rhythm (ventricular tachycardia) that needs treatment.
New York, New YorkAges 18 years+ - NCT05258422Enrolling by invitationPhase 2
Radiation ablation for recurring heart rhythm tachycardia
This study tests a targeted form of radiation therapy to stop a dangerous, repeat heart rhythm called ventricular tachycardia. It’s for people whose rhythm keeps coming back even after standard treatments like antiarrhythmic medications and prior heart procedure studies.
Montreal, QuebecAges 18 years+ - NCT05765175Recruiting
Radioablation versus repeat ablation for hard-to-treat VT
This trial compares a heart procedure using targeted radiation (called radioablation) to a repeat catheter ablation for people with high-risk, hard-to-control ventricular tachycardia (VT). It aims to find which approach is safer and works better after standard ablation and amiodarone have not stopped the abnormal rhythm.
Los Angeles, CaliforniaAges 18 years+ - NCT06669299Recruiting
A heart-rhythm test after ablation to guide next steps
This trial uses a non-invasive stimulation test (NIPS) about a week after a successful ablation procedure for ventricular tachycardia (VT). It aims to see if the test can help doctors decide on further treatment to prevent the fast heart rhythm from returning.
Milan, ItalyAges 18 years+ - NCT06703489Recruiting
New catheter for ventricular tachycardia
This trial tests a new catheter system (Sphere-9 and Affera) to treat a fast, dangerous heartbeat called ventricular tachycardia (VT) in people with heart scarring. It aims to see if this system is safe and effective at stopping VT, especially if past treatments haven't worked.
Boston, MassachusettsAges 18–85 - NCT05594368RecruitingPhase 1
Test targeted radiation to treat recurrent ventricular tachycardia
This trial studies a radiation approach (called stereotactic body radiation therapy, or SBRT) to treat ventricular tachycardia (a dangerous heart rhythm) that keeps coming back. It aims to reduce the rhythm episodes in people who have already tried catheter ablation (a procedure to cauterize rhythm sources) or cannot have it.
OstravaAges 18 years+ - NCT06931821Recruiting
Mapping to guide ablation for ventricular tachycardia
This study tests a new way to map the heart's electrical activity to guide a procedure that destroys the tissue causing fast, dangerous heart rhythms. It's for people with heart disease and ventricular tachycardia that hasn't been controlled by medication.
Phoenix, ArizonaAges 18 years+ - NCT06294028Recruiting
Ablation vs Defibrillator for Well-Tolerated Fast Heartbeat
This study compares two treatments for a fast heartbeat called ventricular tachycardia in people with prior heart attacks and relatively preserved heart function: one uses heat energy (ablation) to fix the electrical problem, and the other places an implantable defibrillator that shocks the heart to restore normal rhythm. The goal is to find which approach works better for people whose symptoms are well-tolerated.
Toulouse, FranceAges 18–90 - NCT06940752Enrolling by invitation
A new way to treat stubborn heart rhythm problems
This study tests a special navigation technique to improve the success of repeat catheter ablation for ventricular arrhythmias, helping patients who haven't been helped by prior procedures or medications.
Atlanta, GeorgiaAges 21–100 - NCT04162171Recruiting
SBRT treatment study for steady heart rhythm VT
This study looks at using SBRT (high-precision radiation) to treat a dangerous, steady heart rhythm called monomorphic VT. It is meant for people who keep having VT even after prior ablation attempts and after trying a class III “rhythm-stabilizing” medicine.
Halifax, Nova ScotiaAges Any age - NCT05337241Recruiting
Saline enhanced needle ablation for stubborn heart rhythm
This trial studies a special “needle” ablation method (with saline) to treat a dangerous, repeat heart rhythm problem called monomorphic ventricular tachycardia (VT). It’s for adults whose VT keeps coming back despite prior treatments and who may not benefit from another standard ablation.
Birmingham, AlabamaAges 18 years+ - NCT06464315Enrolling by invitation
VT Ablation Guided by Scar Tissue Only
This trial tests a new approach to treating a dangerous heart rhythm called ventricular tachycardia (VT) in people with scarred heart muscle. The goal is to use only the scarred area to guide the ablation procedure, which may make it safer and more effective.
San Diego, CaliforniaAges 18–90
Hear when a new Ventricular Tachycardia, Monomorphic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ventricular tachycardia, monomorphic?
- Yes. Clin2 currently lists 17 recruiting ventricular tachycardia, monomorphic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ventricular tachycardia, monomorphic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ventricular tachycardia, monomorphic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.